Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 1381-1384, June 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nielsen, H. R.
Right arrow Articles by Borek, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, H. R.
Right arrow Articles by Borek, E.

ß-Aminoisobutyric Acid, a New Probe for the Metabolism of DNA and RNA in Normal and Tumorous Tissue

Henrik Rist Nielsen1,2, Knud-Erik Sjølin1, Kaare Nyholm1, B. S. Baliga, Rosemary Wong and Ernest Borek

Departments of Clinical Chemistry, Pathology, and Surgery, Sundby Hospital, Copenhagen, Denmark [H. R. N., K-E. S., K. N.], and Department of Microbiology, University of Colorado Medical Center, Denver, Colorado 80220 [B. S. B., R. W., E. B.]

ß-Aminoisobutyric acid, a catabolite of thymine metabolism, originates from the thymine of both DNA and transfer RNA. The ß-aminoisobutyric acid originating from the thymine of DNA and transfer RNA can be distinguished by specific labeling of the former with 14C formate and of the latter with methionine-methyl-3H. Therefore, it can serve as a probe for the metabolism of each macromolecule. In an animal with a rapidly growing tumor (Novikoff hepatoma), the excretion of ß-aminoisobutyric acid diminishes, probably because of the salvage of thymine and its reutilization for DNA synthesis. Such a salvage path is suggested by the increased presence of tritium-labeled thymine in the DNA of the tumor.

AIB3 is a catabolic product that is normally excreted in low levels in human urine (1), and this excretion is elevated in many patients with urothelial tumors (9). Until recently, the origin of this metabolic product was thought to be the thymine of DNA. However, since thymine is present in low levels in tRNA as well, it seemed of interest to ascertain whether AIB may also stem from this source. In a cooperative study in our 2 laboratories, it was determined that the urinary AIB indeed has a dual origin in the normal rat (8). Such a demonstration could be accomplished by taking advantage of the known difference in the pathway of synthesis of the thymine of DNA and of tRNA. The former is synthesized from the 1-carbon pool, with formyltetrahydrofolic acid as the intermediate donor (4). This thymine can, therefore, be labeled by formate-14C. On the other hand, it was shown by Mandel and Borek (5) that the thymine of tRNA is synthesized by the direct addition of an intact methyl group to uracil which had been previously incorporated into the macromolecule. The methyl donor in this reaction is S-adenosylmethionine (3), and the methyl group of the thymine of tRNA can, therefore, be readily labeled with tritium. If the tritiated methyl group should enter the 1-carbon pool, most of its tritium would be exchanged and diluted.

With the availability of such specific markers for DNA and tRNA, a number of hitherto moot questions in the metabolism of these macromolecules can be approached. In this communication we report that AIB is derived, in part, from the thymine of tRNA in normal rats and rats bearing slow-growing Morris hepatomas. However, in rats with the rapidly growing Novikoff hepatoma, excretion of AIB is lower than in the animal prior to the tumor implant. This finding confirms an observation made in vitro by Ferdinandus et al. (2) in their studies of enzyme activities in tumor tissues. They had reported a marked decline in the degradation of thymine via the dihydrothymine and AIB pathway in rapidly growing tumors. Weber has suggested a salvage pathway for thymine in rapidly growing tumors. Our findings of the diminished excretion of AIB in rats bearing Novikoff hepatoma confirm this salvage pathway in the whole animals. However, the diminshed excretion of AIB with both labels implies a salvage pathway of thymine from both DNA and RNA with the possible reincorporation of the thymine into DNA. Such a pathway is implied by data obtained from analysis of 5-methylcytosine and thymine in isolated DNA of the tumor and compared with the same components isolated from the DNA of hepatectomized normal livers.

3 The abbreviation used is: AIB, ß-aminoisobutyric acid.

1 Supported by Grant CA-14047-02 from the NIH, National Cancer Institute, and by the Danish Cancer Society.

2 Supported by Grant j.nr. 512-2115 and -2125.

Received 1/14/74. Accepted 3/ 4/74.




This article has been cited by other articles:


Home page
Plant Physiol.Home page
T. A. Walsh, S. B. Green, I. M. Larrinua, and P. R. Schmitzer
Characterization of Plant {beta}-Ureidopropionase and Functional Overexpression in Escherichia coli
Plant Physiology, February 1, 2001; 125(2): 1001 - 1011.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.